SPOTLIGHT -
Highlights from an expert roundtable meeting
ARVO 2024: Non-invasive testing could use tear film to screen for changes in Huntington Disease
The mutant huntingtin protein in tear fluid may have the potential to serve as an early marker of changes in Huntington disease
Novel Therapies in Neovascular AMD and DME: Achieving Superior Anatomic Outcomes with Fewer Injections
ARVO 2024: Diabetic retinopathy risk factors in paediatric patients with Type 1 diabetes
Study results indicate that maintaining control of blood pressure and hemoglobin A1c are key to preventing the onset of diabetic retinopathy
Long-Term Efficacy and Durability of Latest Therapies in neovascular AMD and DMO
ARVO 2024: New research indicates the need for a new approach to central vision loss
Susana Chung, OD, PhD, speaks about one of her ARVO presentations and the future of artificial intelligence in eye care
ARVO 2024: Murine model of multiple sclerosis demonstrates correlation between visual markers and motor-sensory deficits
Study data demonstrated a significant correlation between visual function, structure and neurological impairment in an experimental autoimmune encephalomyelitis model
